Characterization and localization of [125I]RTI-55-labeled cocaine binding sites in fetal and adult rat brain

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 3, 1996, Pages 1770-1783

  Shearman, Lauren P ^a,b   Collins, Lucille M ^a   Meyer, Jerrold S ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE; DOPAMINE; DOPAMINE RECEPTOR; SEROTONIN; SEROTONIN RECEPTOR; DRUG DERIVATIVE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN MEMBRANE; FETUS; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; ANIMAL; BINDING COMPETITION; BRAIN; DOSE RESPONSE; DRUG EFFECT; FEMALE; METABOLISM; RADIOASSAY; SPRAGUE DAWLEY RAT;

ANIMALS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; BRAIN; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030302506     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. AKBARI, H. M. AND AZMITIA, E. C.: Increased tyrosine hydroxylase immunore-activity in the rat cortex following prenatal cocaine exposure. Dev. Brain Res. 66: 277-281, 1992.
2. AKBARI, H. M., KRAMER, H. K., WHITAKER-AZMITIA, P. M., SPEAR, L. P. AND AZMITIA, E. C.: Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 572: 57-63, 1992.
3. ALTMAN, J. AND BAYER, S. A.: Atlas of Prenatal Rat Brain Development, CRC Press, Boca Raton, 1995.
4. AMARA, S. G. AND KUHAR, M. J.: Neurotransmitter transporters: Recent progress. Annu. Rev. Neurosci. 16: 73-93, 1993.
5. ANDERSEN, P. H.: The dopamine uptake inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166: 493-504, 1989.
6. BLAKELY, R. D., DE FELICE, L. J. AND HARTZELL, H. C.: Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196: 263-281, 1994.
7. BOJA, J. W., CARROLL, F. I., RAHMAN, M. A., PHILIP, A., LEWIN, A. H. AND KUHAR, M. J.: New, potent cocaine analogs: Ligand binding and transport studies in rat striatum. Eur. J. Pharmacol. 184: 329-332, 1990.
8. BOJA, J. W., CLINE, E. J., CARROLL, F. I., LEWIN, A. H., PHILIP, A. DANNALS, R., WONG, D., SCHEFFEL, U. AND KUHAR, M. J.: High potency cocaine analogs: Neurochemical, imaging and behavioral studies. Ann. N.Y. Acad. Sci. 654: 282-291, 1992a.
9. BOJA, J. W., MARKHAM, L., PATEL, A., UHL, G. AND KUHAR, M. J.: Expression of a single dopamine transporter cDNA can confer two cocaine binding sites. NeuroReport 3: 247-248, 1992b.
10. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36, 1992c.
11. 125I]RTI-55: A potent ligand for dopamine transporters. Eur. J. Pharmacol. 194: 133-134, 1991.
12. BOROWSKY, B., MEZEY, E. AND HUFFMAN, B. J.: Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene. Neuron 10: 851-863, 1993.
13. BRADFORD, M. M.: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
14. 3H]dopamine uptake in rat mesencephalic cells in primary cultures: Pharmacologic selectivity of embryonic cocaine sites. Dev. Brain Res. 75: 13-17, 1993.
15. CABRERA, T. M., YRACHETA, J. M., LI, Q., LEVY, A. D., VAN DE KAR, L. D. AND BATTAGLIA, G.: Prenatal cocaine produces deficits in serotonin mediated neuroendocrine responses in adult rat progeny: Evidence for long-term functional alterations in brain serotonin pathways. Synapse 15: 158-168, 1993.
16. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr. Biochem. 7: 87-106, 1988.
17. CARROLL, F. I., LEWIN, A. H., BOJA, J. W. AND KUHAR, M. J.: Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter. J. Med. Chem. 35: 969-981, 1992.
18. CARRUBA, M. O., PICOTTI, G. B., ZAMBOTTI, F. AND MANTEGAZZA, P.: Effects of mazindol, fenfluramine and clomipramine on the 5-hydroxytryptamine uptake and storage mechanisms in rat brain: Similarities and differences. Naunyn-Schmiedeberg's Arch. Pharmacol. 300: 277-232, 1977.
19. 3H]paroxetine binding sites in rat brain. J. Pharmacol. Toxicol. Methods 27: 209-216, 1992.
20. CLARKE, R. L., DAUM, S. J., GAMBINO, A. J., ACETO, M. D., PEARL, J., LEVITT, M., CUMISKEY, W. R. AND BOGADO, E. F.: Compounds affecting the central nervous system. 4-3β-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 16: 1260-1267, 1973.
21. CLINE, E. J., SCHEFFEL, U., BOJA, J. W., CARROLL, F. L, KATZ, J. L. AND KUHAR, M. J.: Behavioral effects of novel cocaine analogs: A comparison with m vivo receptor binding potency. J. Pharmacol. Exp. Ther. 260: 1174-1179, 1992a.
22. 125I]RTI-SS to dopamine transporters: Pharmacology and regional distribution with autoradiography. Synapse 12: 37-46, 1992b.
23. COLLINS, L. M. AND MEYER, J. S.: Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum. Synapse, in press, 1996.
24. 3H]imipramine. J. Pharmacol. Exp. Ther. 242: 364-371, 1987.
25. 125I]RTI-55. J. Chem. Neuroanat. 7: 13-23, 1994.
26. FUJITA, M., SHIMADA, S., NISHIMURA, T., UHL, G. R. AND TOHYAMA, M.: Ontogeny of dopamine transporter mRNA expression in the rat brain. Mol. Brain Res. 19: 222-226, 1993.
27. 3H]CFT) binds to multiple charge-states of the solubilized dopamine transporter in primate striatum. J. Pharmacol. Exp. Ther. 273: 1224-1234, 1995.
28. 3H]biogenic amines in rat brain tissue slices. Eur. J. Pharmacol. 45: 329-333, 1977.
29. 3H]imipramine localization and relationship to serotonin transporter. J. Pharmacol. Exp. Ther. 252: 410-418, 1990.
30. HYDE, C. E. AND BENNETT, B. A.: Similar properties of fetal and adult amine transporters in the rat brain. Brain. Res. 646: 118-123, 1994.
31. HYTTEL, J.: Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry 6: 501-511, 1982.
32. IVGY-MAY, N., TAMIR, H. AND GERSHON, M. D.: Synaptic properties of serotonergic growth cones in developing rat brain. J. Neurosci. 14: 1011-1029, 1994.
33. IZENWASSER, S., ROSENBERGER, J. G. AND Cox, B. M.: The cocaine analog WIN 35,428 binds to two sites in fresh rat caudate-putamen: Significance of assay procedures. Life Sci. 52: PL141-PL145, 1993.
34. 126I]RTI-55. Synapse 12: 99-111, 1992.
35. KELLER, R. W., JR., MAJSONNEUVE, I. M., NUCCIO, D. M., CARLSON, J. N. AND GLICK, S. D.: Effects of prenatal cocaine exposure on the nigrostriatal dopamine system: An in vivo microdialysis study in the rat. Brain Res. 634: 266-274, 1994.
36. KENNEDY, L. T. AND HANBAUER, L: Sodium-sensitive cocaine binding to rat striatal membrane: Possible relationship to dopamine uptake sites. J. Neurochem. 41: 172-178, 1983.
37. 3 receptors in rat brain using radioligand binding. Nature (Lond.) 330: 746-748, 1987.
38. KIRIFIDES, A. L., HARVEY, J, A. AND ALOYO, V. J.: The low affinity binding site for the cocaine analog, Win 35,428, is an artifact of freezing caudate tissue. Life Sci. 50: PL139-PL142, 1992.
39. 3H]5-hydroxytryptamine from fetal and maternal brain by drugs of abuse. Dev. Brain Res. 78: 142-146, 1994.
40. 125I]iodophenyl)tropane-2β-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions. J. Neurochem. 62: 978-986, 1994.
41. LAUDER, J. M.: Neurotransmitters as growth regulatory signals: Role of receptors and second messengers. Trends Neurosci. 16: 233-240, 1993.
42. LESLIE, C. A., ROBERTSON, M. W., JUNG, A. B., LIEBERMANN, J. AND BENNETT, J. P., JR.: Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function. Synapse 17: 210-215, 1994.
43. LEW, R., PATEL, A., VAUGHN, R. A., WILSON, A. AND KUHAR, M. J.: Microheterogeneity of dopamine transporters in rat striatum and nucleus accumbens. Brain Res. 584: 266-271, 1992.
44. LEW, R., VAUGHN, R. A., SIMANTOV, R., WILSON, A. AND KUHAR, M. J.: Dopamine transporters in the nucleus accumbens and the striatum have different apparent molecular weights. Synapse 8: 152-153, 1991.
45. LIDOV, H. G. W. AND MOLLIVER, M. E.: Immunohistochemical study of the development of serotonergic neurons in the rat CNS. Brain Res. Bull. 9: 559-604, 1982.
46. 125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain. J. Neurochem. 61: 1996-2006, 1993.
47. LIU, Q.-R., LOPEZ-CORCUERA, B., MANDIYAN, S., NELSON, H. AND NELSON, N.: Molecular characterization of four pharmacologically distinct γ-aminobutyric acid transporters in mouse brain. J. Biol. Chem. 268: 2106-2112, 1993.
48. 3H]cocaine binding sites in caudate-putamen. J. Pharmacol. Exp. Ther. 251: 131-141, 1989a.
49. 3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane. Mol. Pharmacol. 36: 518-524, 1989b.
50. MATTHEWS, J. C. AND COLLINS, A.: Interaction of cocaine and cocaine congeners with sodium channels. Biochem. Pharmacol. 32: 455-460, 1983.
51. MELTZER, P. C., LIANG, A. Y. AND MADRAS, B. K.: The discovery of an unusually selective and novel cocaine analog: Difluoropine. Synthesis and inhibition of binding at cocaine recognition sites. J. Med. Chem. 37: 2001-2010, 1994.
52. MEYER, J. S., SHEARMAN, L. P., COLLINS, L. M. AND MAGUIRE, R. L.: Cocaine binding sites in fetal rat brain: Implications for prenatal cocaine action. Psychopharmacology 112: 445-451, 1993.
53. MILIUS, R. A., SAHA, J. K., MADRAS, B. K. AND NEUMEYER, J. L.: Synthesis and receptor binding of n-substituted tropane derivatives. High affinity ligands for the cocaine receptor. J. Med. Chem. 34: 1728-1731, 1991.
54. MINABE, Y., ASHBY, C. R., JR, HEYSER, C., SPEAR, L. P. AND WANG, R. Y.: The effects of prenatal cocaine exposure on spontaneously active midbrain dopamine neurons in adult male offspring: An electrophysiological study. Brain Res. 586: 152-156, 1992.
55. PATEL, A., CERRUTI, C. AND KUHAR, M. J.: Changes in molecular mass of rat striatal dopamine transporter during postnatal development. Soc. Neurosci. Abstr. 19: 3, 1993a.
56. PATEL, A., UHL, G. AND KUHAR, M. J.: Species differences in dopamine transporters: Postmortem changes and glycosylation differences. J. Neurochem. 61: 496-500, 1993b.
57. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, San Diego, 1986.
58. 3H]WIN 35,428 binding to the dopamine uptake carrier. II. Effect of membrane fractionation procedure and freezing. J. Neurosci. Methods 51: 31-38, 1994.
59. 3H]batrachotoxinin A. 20-α-benzoate binding sites on sodium channels in mouse brain synaptosomes. J. Biol. Chem. 261: 7300-7305, 1986.
60. 3H]cocaine binding in brain is inhibited by Tris (hydroxymethyl) aminomethane. J. Neurosci. Methods 12: 151-154, 1984.
61. 3H]cocaine binding in brain is associated with serotonergic neurons. Mol. Pharmacol. 23: 600-606, 1983.
62. 3H]cocaine binding in central nervous system of mouse. Life Sci. 27: 1055-1062, 1980.
63. RICHELSON, E. AND PFENNING, M.: Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104: 272-286, 1982.
64. RITZ, M. C., LAMB, R. J., GOLDBERG, S. R. AND KUHAR, M. J.: Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash. DC) 237: 1219-1223, 1987.
65. ROTHMAN, R. B., LEWIS, B., DERSCH, C., XU, H., RADESCA, L., DE COSTA, B. R., RICE, K. C., KILBURN, R. B., AKUNNE, H. C. AND PERT, A.: Identification of a GBR 12935 homolog, L R 1111, which is over 4,000-fold more selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14: 34-39, 1993.
66. RUDNICK, G. AND CLARK, J.: From synapse to vesicle: The reuptake and storage of biogenic amine neurotransmitters. Biochim. Biophys. Acta 1144: 249-263, 1993.
67. 3H]carboxyme-thoxy-3β-(4-fluorophenyl)tropane to the serotonin transporter. Mol. Pharmacol. 40: 421-426, 1991.
68. 125I]RTI-55, an in vivo label for the serotonin transporter. Synapse 11: 134-139, 1992.
69. SHARKEY, J., GLEN, K. A., WOLFE, S. AND KUHAR, M. J.: Cocaine binding at sigma receptors. Eur. J. Pharmacol. 149: 171-174, 1988a.
70. SHARKEV, J., RITZ, M. C., SCHENDEN, J. A., HANSON, R. C. AND KUHAR, M. J.: Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J. Pharmacol. Exp. Ther. 246: 1048-1052, 1988b.
71. SHEARMAN, L. P., KOMAN, A. AND MEYER, J. S.: Prenatal ontogeny of norepinephrine transporter binding in the rat brain. Soc. Neurosci. Abstr. 21: 705, 1995.
72. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn-Schmiedeberg's Arch. Pharmacol. 329: 227-235, 1985.
73. SNYDER-KELLER, A. M. AND KELLER, R. W., JR.: Prenatal cocaine increases striatal serotonin innervation without altering the patch/matrix organization of intrinsic cell types. Dev. Brain Res. 74: 261-267, 1993.
74. 125I]RTI-55: In vitro binding and autoradiographic characterization. J. Neurochem. 62: 549-556, 1994.
75. 2 dopamine receptor and dopamine transporter gene expression in the rat mesencephalon. Neurosci. Lett. 166: 48-50, 1994.
76. VAUGHN, R. A., MCCOY, M. T. AND KUHAR, M. J.: Charge isoforms of dopamine transporters. Soc. Neurosci. Abstr. 18: 1433, 1992.
77. 125I]iodophenyl)tropane binding. Mol. Pharmacol. 43: 264-270, 1993.
78. WANG, L. AND PITTS, D. K.: Perinatal cocaine exposure decreases the number of spontaneously active midbrain dopamine neurons in neonatal rats. Synapse 17: 275-277, 1994.
79. WONG, D. T. AND BYMASTER, F. P.: Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete areas of brain. Biochem. Pharmacol. 25: 1979-1983, 1976.